Infinity Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 11.05 million compared to USD 12.44 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.14 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.96% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- INFI.Q Stock
- News Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023